These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1683422

  • 1. Production of interleukin-1-receptor antagonist during experimental endotoxaemia.
    Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA.
    Lancet; 1991 Dec 07; 338(8780):1423-4. PubMed ID: 1683422
    [Abstract] [Full Text] [Related]

  • 2. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.
    Granowitz EV, Porat R, Mier JW, Orencole SF, Callahan MV, Cannon JG, Lynch EA, Ye K, Poutsiaka DD, Vannier E.
    Blood; 1993 Nov 15; 82(10):2985-90. PubMed ID: 8219190
    [Abstract] [Full Text] [Related]

  • 3. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.
    Vannier E, Miller LC, Dinarello CA.
    Proc Natl Acad Sci U S A; 1992 May 01; 89(9):4076-80. PubMed ID: 1533284
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.
    Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, DeForge L, Kenney JS, Remick DG, Bloedow DC.
    J Clin Invest; 1992 May 01; 89(5):1551-7. PubMed ID: 1533231
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation.
    Bertini R, Sironi M, Martin-Padura I, Colotta F, Rambaldi S, Bernasconi S, Ghezzi P, Haskill SJ, Liu D, Mantovani A.
    Cytokine; 1992 Jan 01; 4(1):44-7. PubMed ID: 1377516
    [Abstract] [Full Text] [Related]

  • 6. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.
    Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA.
    J Exp Med; 1991 Apr 01; 173(4):1029-32. PubMed ID: 1826127
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-1 receptor antagonist: an index of dialysis-induced interleukin-1 production.
    Pereira BJ, King AJ, Falagas ME, Dinarello CA.
    Nephron; 1994 Apr 01; 67(3):358-61. PubMed ID: 7936030
    [Abstract] [Full Text] [Related]

  • 8. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.
    Ulich TR, Guo K, Yin S, del Castillo J, Yi ES, Thompson RC, Eisenberg SP.
    Am J Pathol; 1992 Jul 01; 141(1):61-8. PubMed ID: 1385928
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL.
    J Exp Med; 1991 Apr 01; 173(4):931-9. PubMed ID: 1826128
    [Abstract] [Full Text] [Related]

  • 10. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation.
    Ulich TR, Yin SM, Guo KZ, del Castillo J, Eisenberg SP, Thompson RC.
    Am J Pathol; 1991 Mar 01; 138(3):521-4. PubMed ID: 1825745
    [Abstract] [Full Text] [Related]

  • 11. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants.
    Nicod LP, el Habre F, Dayer JM.
    Cytokine; 1992 Jan 01; 4(1):29-35. PubMed ID: 1535518
    [Abstract] [Full Text] [Related]

  • 12. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma.
    O'Nualláin EM, Puri P, Mealy K, Reen DJ.
    Clin Immunol Immunopathol; 1995 Jul 01; 76(1 Pt 1):96-101. PubMed ID: 7606873
    [Abstract] [Full Text] [Related]

  • 13. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
    Dinarello CA, Thompson RC.
    Immunol Today; 1991 Nov 01; 12(11):404-10. PubMed ID: 1838480
    [Abstract] [Full Text] [Related]

  • 14. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.
    van Deuren M, van der Ven-Jongekrijg J, Vannier E, van Dalen R, Pesman G, Bartelink AK, Dinarello CA, van der Meer JW.
    Blood; 1997 Aug 01; 90(3):1101-8. PubMed ID: 9242541
    [Abstract] [Full Text] [Related]

  • 15. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    McColl SR, Paquin R, Ménard C, Beaulieu AD.
    J Exp Med; 1992 Aug 01; 176(2):593-8. PubMed ID: 1386877
    [Abstract] [Full Text] [Related]

  • 16. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.
    Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA.
    FASEB J; 1991 Mar 01; 5(3):338-43. PubMed ID: 1825816
    [Abstract] [Full Text] [Related]

  • 17. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P, Klein-Nulend J, Alander C, Thompson RC, Dayer JM, Raisz LG.
    J Immunol; 1990 Dec 15; 145(12):4181-4. PubMed ID: 2147937
    [Abstract] [Full Text] [Related]

  • 18. Fc gamma receptor cross-linking down-regulates IL-1 receptor antagonist and induces IL-1 beta in mononuclear phagocytes stimulated with endotoxin or Staphylococcus aureus.
    Marsh CB, Pope HA, Wewers MD.
    J Immunol; 1994 May 01; 152(9):4604-11. PubMed ID: 8157973
    [Abstract] [Full Text] [Related]

  • 19. Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production.
    Poutsiaka DD, Mengozzi M, Vannier E, Sinha B, Dinarello CA.
    Blood; 1993 Dec 15; 82(12):3695-700. PubMed ID: 7505123
    [Abstract] [Full Text] [Related]

  • 20. Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats.
    Schotanus K, Tilders FJ, Berkenbosch F.
    Endocrinology; 1993 Dec 15; 133(6):2461-8. PubMed ID: 8243265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.